PODCAST: How Deciphex is Accelerating the Non-clinical Drug Development Phase - Interview with Aleksandra Zuraw
Our CEO Donal O’Shea featured on the Digital Pathology Space’s podcast hosted by Aleksandra Zuraw this week to discuss how Deciphex is accelerating the non-clinical drug development phase.
News
Share
Our CEO Donal O’Shea featured on the Digital Pathology Space’s podcast hosted by Aleksandra Zuraw this week to discuss how Deciphex is accelerating the non-clinical drug development phase.
In this podcast Donal discusses his journey to where he is now and how Deciphex came to be, the growth of Deciphex over the past two years, the company’s mission, and the value Deciphex brings to the non-clinical digital pathology market.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
